Ellipses Pharma
London oncology drug developer that in-licenses cancer assets and funds them through clinical trials.
ellipses.life ↗Why it's here
Pivotal trial data for its RET inhibitor EP0031 was presented at ASCO 2026 by partner Kelun-Biotech, and it in-licensed a B7H3 ADC in Jan 2026.
source: ellipses.life- Focus
- Oncology Drug Development
- Founded
- 2015
- London office
- 10 Stratton Street, Westminster W1J 8LGsource: ellipses.life
- London presence
- HQsource: ellipses.life
- Investors
- West Coast Capitalsource: scottishfinancialnews.com
- Nearest station
- Green Park, 119 m
- Visas
- Licensed visa sponsor, listed as Ellipses Pharma Ltdsource: gov.uk
Verified 6 Oct 2026. How we verify · Suggest a fix
For Ellipses Pharma
Work here? Show you're on the map. Add the badge to your site or README, or share the listing.
<a href="https://londonmempool.co.uk/c/ellipses-pharma"><img src="https://londonmempool.co.uk/badge/ellipses-pharma.svg" alt="Ellipses Pharma is listed on London Mempool" width="357" height="28"></a>
Add ?theme=light to the image URL for light backgrounds.